Petrus Trust Company’s RxSight RXST Stock Holding History

Petrus Trust Company’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,651	Closed	-$496K	–	691
2025 Q1	$496K	Buy	19,651 +938	+5%	+$27.9K	0.05%	196
2024 Q4	$643K	Buy	18,713 +13,781	+279%	+$621K	0.06%	127
2024 Q3	$244K	Sell	4,932 -347	-7%	-$17.8K	0.02%	475
2024 Q2	$318K	Sell	5,279 -4,885	-48%	-$279K	0.03%	412
2024 Q1	$524K	Sell	10,164 -4,098	-29%	-$201K	0.05%	189
2023 Q4	$575K	Buy	+14,262	New	+$418K	0.05%	171

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Petrus Trust Company's RXST Position: Q2 2025 in Review

Petrus Trust Company sold out of RxSight (RXST) in Q2 2025, closing a stake of 19,651 shares — an estimated $496K sold.

Petrus Trust Company first reported a position in RXST in Q4 2023 and held it in 6 quarters. The position peaked at $643K in Q4 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

Petrus Trust Company reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
Petrus Trust Company sold 19,651 RxSight shares in Q2 2025, an estimated $496K.
Petrus Trust Company first reported a position in RxSight in Q4 2023 and held it in 6 quarters.
Petrus Trust Company's RxSight position peaked at $643K in Q4 2024.
174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Petrus Trust Company's 13F filing for Q2 2025, filed 14 Aug 2025.